These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7988609)

  • 21. Immunosuppression with high doses of cyclophosphamide reduces the severity of myocarditis but increases the mortality in murine Coxsackievirus B3 myocarditis.
    Kishimoto C; Thorp KA; Abelmann WH
    Circulation; 1990 Sep; 82(3):982-9. PubMed ID: 2168299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracardiac thrombus in murine Coxsackievirus B3 myocarditis.
    Kishimoto C; Ochiai H; Sasayama S
    Heart Vessels; 1992; 7(2):76-81. PubMed ID: 1328146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coxsackievirus B3 myocarditis in C3H/HeJ mice: description of an inbred model and the effect of exercise on virulence.
    Kiel RJ; Smith FE; Chason J; Khatib R; Reyes MP
    Eur J Epidemiol; 1989 Sep; 5(3):348-50. PubMed ID: 2551723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac myosin and autoimmune myocarditis.
    Rose NR; Beisel KW; Herskowitz A; Neu N; Wolfgram LJ; Alvarez FL; Traystman MD; Craig SW
    Ciba Found Symp; 1987; 129():3-24. PubMed ID: 2824143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of indomethacin in the late phase of coxsackievirus myocarditis in a murine model.
    Rezkalla S; Khatib R; Khatib G; Smith F; Walsh M; Sowers J; Kloner R
    J Lab Clin Med; 1988 Jul; 112(1):118-21. PubMed ID: 2839587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ventricular aneurysms and ventricular arrhythmias complicating Coxsackie virus B1 myocarditis of Syrian golden hamsters.
    Hoshino T; Matsumori A; Kawai C; Imai J
    Cardiovasc Res; 1984 Jan; 18(1):24-9. PubMed ID: 6318997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alterations in coxsackievirus B4 heart muscle disease in ICR Swiss mice by anti-thymocyte serum.
    Khatib R; Khatib G; Chason JL; Lerner AM
    J Gen Virol; 1983 Jan; 64 (Pt 1)():231-6. PubMed ID: 6296300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Absence of effects of cyclosporine on myocardial lymphocyte subsets in Coxsackievirus B3 myocarditis in the aviremic stage.
    Kishimoto C; Abelmann WH
    Circ Res; 1989 Oct; 65(4):934-45. PubMed ID: 2551533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successive infection of coxsackievirus B3 and encephalomyocarditis virus: an animal model of chronic myocarditis.
    Okada I; Matsumori A; Tomioka N; Kawai C
    J Pathol; 1992 Jul; 167(3):341-7. PubMed ID: 1325552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Persistence of replicating coxsackievirus B3 in the athymic murine heart is associated with development of myocarditic lesions.
    Sato S; Tsutsumi R; Burke A; Carlson G; Porro V; Seko Y; Okumura K; Kawana R; Virmani R
    J Gen Virol; 1994 Nov; 75 ( Pt 11)():2911-24. PubMed ID: 7964602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trace element distribution in heart tissue sections studied by nuclear microscopy is changed in Coxsackie virus B3 myocarditis in methyl mercury-exposed mice.
    Ilbäck NG; Lindh U; Wesslén L; Fohlman J; Friman G
    Biol Trace Elem Res; 2000; 78(1-3):131-47. PubMed ID: 11314973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of metoprolol in acute coxsackievirus B3 murine myocarditis.
    Rezkalla S; Kloner RA; Khatib G; Smith FE; Khatib R
    J Am Coll Cardiol; 1988 Aug; 12(2):412-4. PubMed ID: 2839568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of levosimendan in experimental acute coxsackievirus myocarditis.
    Latva-Hirvelä J; Kytö V; Saraste A; Vuorinen T; Levijoki J; Saukko P
    Eur J Clin Invest; 2009 Oct; 39(10):876-82. PubMed ID: 19772522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of MIP-2 in coxsackievirus B3 myocarditis.
    Kishimoto C; Kawamata H; Sakai S; Shinohara H; Ochiai H
    J Mol Cell Cardiol; 2000 Apr; 32(4):631-8. PubMed ID: 10756119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of delayed captopril therapy on left ventricular mass and myonecrosis during acute coxsackievirus murine myocarditis.
    Rezkalla S; Kloner RA; Khatib G; Khatib R
    Am Heart J; 1990 Dec; 120(6 Pt 1):1377-81. PubMed ID: 2174203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Left ventricular hemodynamic parameters in the course of acute experimental coxsackievirus B 3 myocarditis.
    Herzum M; Weller R; Jomaa H; Wietrzychowski F; Pankuweit S; Mahr P; Maisch B
    J Mol Cell Cardiol; 1995 Aug; 27(8):1573-80. PubMed ID: 8523420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trace element changes in the myocardium during coxsackievirus B3 myocarditis in the mouse.
    Funseth E; Lindh U; Wesslén L; Friman G; Ilbäck NG
    Biol Trace Elem Res; 2000 Aug; 76(2):149-60. PubMed ID: 11049229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fasudil exerts a cardio-protective effect on mice with coxsackievirus B3-induced acute viral myocarditis.
    Dai K; Wang Y; Tai S; Ni H; Lian H; Yu Y; Liao W; Zheng C; Chen Q; Kuver A; Li J
    Cardiovasc Ther; 2018 Dec; 36(6):e12477. PubMed ID: 30380183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of granulocyte colony-stimulating factor upon coxsackievirus B3 myocarditis in mice.
    Hiraoka Y; Kishimoto C; Takada H; Suzaki N; Shiraki K
    Eur Heart J; 1995 Dec; 16(12):1900-6. PubMed ID: 8682024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beneficial effects of captopril in acute coxsackievirus B3 murine myocarditis.
    Rezkalla S; Kloner RA; Khatib G; Khatib R
    Circulation; 1990 Mar; 81(3):1039-46. PubMed ID: 2155071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.